Literature DB >> 34340257

Haemophilia care: the only constant is change.

Benjamin J Samelson-Jones1,2, Lindsey A George1,2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34340257      PMCID： PMC8939393          DOI： 10.1111/bjh.17661

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  19 in total

1.  Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?

Authors:  Glenn F Pierce; Radoslaw Kaczmarek; Declan Noone; Brian O'Mahony; David Page; Mark W Skinner
Journal:  Haemophilia       Date:  2020-09-10       Impact factor: 4.287

2.  A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model.

Authors:  Takehisa Kitazawa; Tomoyuki Igawa; Zenjiro Sampei; Atsushi Muto; Tetsuo Kojima; Tetsuhiro Soeda; Kazutaka Yoshihashi; Yukiko Okuyama-Nishida; Hiroyuki Saito; Hiroyuki Tsunoda; Tsukasa Suzuki; Hideki Adachi; Taro Miyazaki; Shinya Ishii; Mika Kamata-Sakurai; Takeo Iida; Aya Harada; Keiko Esaki; Miho Funaki; Chifumi Moriyama; Eriko Tanaka; Yasufumi Kikuchi; Tetsuya Wakabayashi; Manabu Wada; Masaaki Goto; Takeshi Toyoda; Atsunori Ueyama; Sachiyo Suzuki; Kenta Haraya; Tatsuhiko Tachibana; Yoshiki Kawabe; Midori Shima; Akira Yoshioka; Kunihiro Hattori
Journal:  Nat Med       Date:  2012-09-30       Impact factor: 53.440

3.  Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

Authors:  Johannes Oldenburg; Johnny N Mahlangu; Benjamin Kim; Christophe Schmitt; Michael U Callaghan; Guy Young; Elena Santagostino; Rebecca Kruse-Jarres; Claude Negrier; Craig Kessler; Nancy Valente; Elina Asikanius; Gallia G Levy; Jerzy Windyga; Midori Shima
Journal:  N Engl J Med       Date:  2017-07-10       Impact factor: 91.245

4.  Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.

Authors:  Johnny Mahlangu; Johannes Oldenburg; Ido Paz-Priel; Claude Negrier; Markus Niggli; M Elisa Mancuso; Christophe Schmitt; Victor Jiménez-Yuste; Christine Kempton; Christophe Dhalluin; Michael U Callaghan; Willem Bujan; Midori Shima; Joanne I Adamkewicz; Elina Asikanius; Gallia G Levy; Rebecca Kruse-Jarres
Journal:  N Engl J Med       Date:  2018-08-30       Impact factor: 91.245

5.  Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.

Authors:  Isabella McCary; Christine Guelcher; Jan Kuhn; Regina Butler; Gita Massey; Michael F Guerrera; Lance Ballester; Leslie Raffini
Journal:  Haemophilia       Date:  2020-04-20       Impact factor: 4.287

Review 6.  The 'royal disease'--haemophilia A or B? A haematological mystery is finally solved.

Authors:  N Lannoy; C Hermans
Journal:  Haemophilia       Date:  2010-11       Impact factor: 4.287

7.  Activated protein C has a regulatory role in factor VIII function.

Authors:  Amelia R Wilhelm; Nicole A Parsons; Benjamin J Samelson-Jones; Robert J Davidson; Charles T Esmon; Rodney M Camire; Lindsey A George
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

Review 8.  Current Clinical Applications of In Vivo Gene Therapy with AAVs.

Authors:  Jerry R Mendell; Samiah A Al-Zaidy; Louise R Rodino-Klapac; Kimberly Goodspeed; Steven J Gray; Christine N Kay; Sanford L Boye; Shannon E Boye; Lindsey A George; Stephanie Salabarria; Manuela Corti; Barry J Byrne; Jacques P Tremblay
Journal:  Mol Ther       Date:  2020-12-10       Impact factor: 11.454

9.  Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.

Authors:  Brian R Long; Philippe Veron; Klaudia Kuranda; Romain Hardet; Nina Mitchell; Gregory M Hayes; Wing Yen Wong; Kelly Lau; Mingjin Li; M Benjamin Hock; Stephen J Zoog; Christian Vettermann; Federico Mingozzi; Becky Schweighardt
Journal:  Mol Ther       Date:  2020-12-10       Impact factor: 11.454

Review 10.  Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy.

Authors:  Benjamin J Samelson-Jones; Valder R Arruda
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-31       Impact factor: 6.698
View more
  1 in total

Review 1.  Immunotherapy and Gene Therapy: New Challenges in the Diagnosis and Management of Drug-Induced Liver Injury.

Authors:  Bénédicte Delire; Eleonora De Martin; Lucy Meunier; Dominique Larrey; Yves Horsmans
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.